We are the first to provide evidence that altered SAV1 protein expression is related to unfavorable clinicopathological parameters in CRC patients, such as lymph node involvement and higher TNM disease stage and histological grade, and, thus, appears to be involved in CRC progression. Here, SAV1 is linked to colorectal carcinoma.